Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lafayette, LA
NPI
1881790632
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4212 W Congress St Ste 2300a
Lafayette, LA, 70506
Phone (337) 237-7801
Groups this clinician bills Medicare through
Medicare paid, 2024
$460K
19,080 services
Medicare patients, 2024
1,185
Average age 73
Drug cost, 2024
$2.0M
5,791 prescriptions
Company payments, 2025
$73K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justin W Fontenot was code J0897 (injection, denosumab, 1 mg), 10,320 times for 103 patients. In total Justin W Fontenot billed 19,080 services in 46 codes, and Medicare paid $460K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 10,320 | 103 | $20.41 | $211K |
| 36415 Venipuncture Blood Collection | Office | 1,346 | 910 | $8.61 | $12K |
| 99214 Office E&M - Established | Office | 1,182 | 876 | $80.00 | $95K |
| 84443 Clinical Chemistry | Office | 694 | 528 | $16.27 | $11K |
| 84439 Clinical Chemistry | Office | 609 | 457 | $8.72 | $5,313 |
| 83036 Blood Count | Office | 472 | 342 | $9.23 | $4,356 |
| 84550 Clinical Chemistry | Office | 388 | 319 | $4.39 | $1,704 |
| 84100 Clinical Chemistry | Office | 387 | 318 | $4.61 | $1,784 |
| 82248 Clinical Chemistry | Office | 387 | 318 | $4.88 | $1,887 |
| 82550 Clinical Chemistry | Office | 387 | 318 | $6.32 | $2,447 |
| 80053 Clinical Chemistry | Office | 384 | 315 | $10.26 | $3,939 |
| 76536 Ultrasound - Nonspecific | Office | 360 | 348 | $72.25 | $26K |
| 95251 Test - Miscellaneous | Office | 265 | 163 | $23.53 | $6,236 |
| 82948 Clinical Chemistry | Office | 247 | 179 | $4.81 | $1,188 |
| 82306 Clinical Chemistry | Office | 216 | 203 | $29.01 | $6,266 |
By year: 2022 $458K for 20,581 services; 2023 $514K for 22,047 services; 2024 $460K for 19,080 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,346 | 910 | $8.61 | $12K |
| 84443 Clinical Chemistry | 694 | 528 | $16.27 | $11K |
| 84439 Clinical Chemistry | 609 | 457 | $8.72 | $5,313 |
| 83036 Blood Count | 472 | 342 | $9.23 | $4,356 |
| 84550 Clinical Chemistry | 388 | 319 | $4.39 | $1,704 |
| 82550 Clinical Chemistry | 387 | 318 | $6.32 | $2,447 |
| 82248 Clinical Chemistry | 387 | 318 | $4.88 | $1,887 |
| 84100 Clinical Chemistry | 387 | 318 | $4.61 | $1,784 |
| 80053 Clinical Chemistry | 384 | 315 | $10.26 | $3,939 |
| 82948 Clinical Chemistry | 247 | 179 | $4.81 | $1,188 |
Medicare prescription drug claims, 2024
In 2024, the drug Justin W Fontenot prescribed most often to Medicare patients was Levothyroxine Sodium, with 939 prescriptions and refills. In total Justin W Fontenot wrote 5,791 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 939 | 1,906 | 235 | $7,350 |
| Synthroid Levothyroxine Sodium | 476 | 794 | 105 | $31K |
| Mounjaro Tirzepatide | 237 | 279 | 51 | $285K |
| Metformin Hcl Generic | 227 | 516 | 65 | $2,021 |
| Ozempic Semaglutide | 204 | 247 | 41 | $219K |
| Hydrocortisone Generic | 193 | 271 | 31 | $5,881 |
| Methimazole Generic | 174 | 330 | 59 | $1,075 |
| Alendronate Sodium Generic | 172 | 263 | 32 | $1,294 |
| Jardiance Empagliflozin | 170 | 265 | 34 | $148K |
| Pioglitazone Hcl Generic | 151 | 297 | 35 | $1,668 |
| Cinacalcet Hcl Generic | 116 | 163 | 25 | $75K |
| Metformin Hcl Er Metformin Hcl | 98 | 206 | 29 | $1,273 |
| Glimepiride Generic | 94 | 214 | 34 | $944 |
| Farxiga Dapagliflozin Propanediol | 93 | 175 | 21 | $96K |
| Lisinopril Generic | 89 | 177 | 24 | $249 |
Brand drugs: 2,547 claims; generic drugs: 2,979 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Justin W Fontenot $73K ($73K in general payments such as food, travel and fees) from 29 companies. The largest payer was Lilly USA, LLC with $39K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 65 | $39K |
| Amgen Inc. AMGN | 54 | $32K |
| Beta Bionics, Inc. BBNX | 8 | $297 |
| Abbott Laboratories ABT | 5 | $202 |
| Insulet Corporation PODD | 8 | $167 |
| Dexcom, Inc. DXCM | 13 | $163 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $127 |
| Radius Health, Inc. | 4 | $103 |
| UCB, Inc. UCB.BR | 3 | $89.81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.